Did you know that Control-IQ™ technology for the t:slim X2™ insulin pump is now cleared for ages 6 and up? Check out our latest blog post to learn more... | By Tandem
![A Randomized Trial Evaluating the Efficacy and Safety of Control-IQ Technology in Adults with Type 2 Diabetes Using Basal-Bolus Insulin Therapy (2IQP) | Clinical Research Studies Listing ( In person and virtual A Randomized Trial Evaluating the Efficacy and Safety of Control-IQ Technology in Adults with Type 2 Diabetes Using Basal-Bolus Insulin Therapy (2IQP) | Clinical Research Studies Listing ( In person and virtual](https://clinicalresearch.pennmedicine.org/media/img/iconnect_FINAL_2.png)
A Randomized Trial Evaluating the Efficacy and Safety of Control-IQ Technology in Adults with Type 2 Diabetes Using Basal-Bolus Insulin Therapy (2IQP) | Clinical Research Studies Listing ( In person and virtual
![Tandem Diabetes Care Announces FDA Clearance of the t:slim X2 Insulin Pump with Control-IQ Advanced Hybrid Closed-Loop Technology | Business Wire Tandem Diabetes Care Announces FDA Clearance of the t:slim X2 Insulin Pump with Control-IQ Advanced Hybrid Closed-Loop Technology | Business Wire](https://mms.businesswire.com/media/20191213005424/en/762891/22/t_slim.jpg)
Tandem Diabetes Care Announces FDA Clearance of the t:slim X2 Insulin Pump with Control-IQ Advanced Hybrid Closed-Loop Technology | Business Wire
![Visualization of Control IQ and Basal IQ events from Tandem t:slim X2 – Glooko Support | Help Center Visualization of Control IQ and Basal IQ events from Tandem t:slim X2 – Glooko Support | Help Center](https://support.glooko.com/hc/article_attachments/360016558938/Screen_Shot_2021-01-28_at_11.47.56_PM.png)